TherapeuticsMD Inc (NASDAQ:TXMD)

7.13
Delayed Data
As of Jun 15
 +0.25 / +3.63%
Today’s Change
4.30
Today|||52-Week Range
7.66
+18.05%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2014

2015

2016

2017
Operating ActivitiesNet Income / Starting Line-54.2M-85.1M-89.9M-76.9M
 
 
 
 
 
Depreciation52.5K62.4K132.5K213.1K
 
 
 
 
 
Total Other Cash Flow5.2M7.2M19.9M6.9M
 
 
 
 
 
Funds From Operations-48.9M-77.8M-69.8M-69.8M
 
 
 
 
 
Funds From/For Other Operating Expenses-3.4M1.2M-664.7K6.3M
 
 
 
 
 
Net Cash Flow - Operating Activities-45.5M-79.0M-69.1M-76.2M
 
 
 
 
 
 
InvestingCapital Expenditures-31.0K-165.3K-396.2K-61.8K
 
 
 
 
 
Other Investing - Uses10.7K0.00-14.0K0.00
 
 
 
Net Cash Flow Investing-606.8K-584.4K-1.3M-827.1K
 
 
 
 
 
 
FinancingShort Term Borrowings0.000.000.000.00--
Long Term Borrowings0.000.000.000.00--
Long Term Debt Reduction0.000.000.000.00--
Net Proceeds Stock Sale43.3M93.0M137.2M72.6M
 
 
 
 
 
Common Preferred Redeemed0.000.000.000.00--
Common Dividends0.000.000.000.00--
Cash Dividends Paid - Total0.000.000.000.00--
Other Sources - Financing0.000.000.000.00--
Other Uses - Financing0.000.000.000.00--
Net Cash Flow - Financing43.3M93.0M137.2M72.6M
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash0.00--------
 
Net Change In Cash-2.8M13.3M66.8M-4.4M